Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a ...

Intech Investment Management LLC acquired a new stake in shares of HilleVax, Inc. (NASDAQ:HLVX – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with ...

Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.

BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial ...

The global animal vaccines market size was US$ 8.5 billion in 2021. The global animal vaccines market is forecast to grow to US$ 13.3 billion by 2030 by growing at a compound annual growth rate (CAGR) ...

A local Bucks County adult tested positive for measles after returning from a trip to Texas, health officials said.

December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults ...

Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...

A new CRISPR-based technology, called RIDE, is a leap forward for this trail-blazing technology. With the precision of a ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

Particle Network is a Modular L1 Unifying All Chains Through Universal Accounts, achieving "One Account, One Balance, Any Chain" to address Web3's user and liquidity fragmentation issues. Particle ...